跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BEPRAZ GASTRO RESISTANT TABLETS 10MG - HSA Drug Approval Details
Approvals
/
HSA
/
BEPRAZ GASTRO RESISTANT TABLETS 10MG
Approved
THERAPEUTIC
BEPRAZ GASTRO RESISTANT TABLETS 10MG
Sun Pharmaceutical Industries Limited
🇸🇬 Health Sciences Authority
Approval Date
Jun 7, 2017
Approval ID
b8f956cafae3196b
Company
Sun Pharmaceutical Industries Limited
Type
Therapeutic
Approval Details
Approval Id
b8f956cafae3196b
Drug Name
BEPRAZ GASTRO RESISTANT TABLETS 10MG
Product Name
BEPRAZ GASTRO RESISTANT TABLETS 10MG
Approval Number
SIN15260P
Approval Date
2017-06-07
Registrant
RANBAXY (MALAYSIA) SDN. BHD.
Licence Holder
RANBAXY (MALAYSIA) SDN. BHD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, DELAYED RELEASE
Route Of Administration
ORAL
Atc Code
A02BC04
Atc Item Name
rabeprazole
Pharma Manufacturer Name
RANBAXY (MALAYSIA) SDN. BHD.
Company Detail Path
/organization/ranbaxy-malaysia-sdn-bhd
Active Ingredients
Rabeprazole free base 9.42mg eqv Rabeprazole Sodium
10mg
Rabeprazole free base 9.42mg eqv Rabeprazole Sodium
10mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jun 7, 2017
Approval ID
b8f956cafae3196b
Type
Therapeutic
Back to HSA Approvals